Holen Sie sich die Stockscreener-App
165.44
1.61%
2.62
Handel nachbörslich:
165.44
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$162.82
Offen:
$162.11
24-Stunden-Volumen:
1.80M
Relative Volume:
1.99
Marktkapitalisierung:
$9.59B
Einnahmen:
$16.08B
Nettoeinkommen (Verlust:
$1.20B
KGV:
9.284
EPS:
17.82
Netto-Cashflow:
$1.06B
1W Leistung:
+0.38%
1M Leistung:
-7.10%
6M Leistung:
-12.60%
1J Leistung:
-23.09%
1-Tages-Spanne:
$161.18
$166.50
1-Wochen-Bereich:
$152.33
$166.50
52-Wochen-Spanne:
$152.33
$243.25
Universal Health Services Inc Stock (UHS) Company Profile
Firmenname
Universal Health Services Inc
Sektor
Branche
Telefon
(610) 768-3300
Adresse
367 S GULPH RD, KING OF PRUSSIA, PA
Vergleichen Sie UHS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UHS
Universal Health Services Inc
|
165.44 | 10.49B | 16.08B | 1.20B | 1.06B | 17.82 |
|
HCA
Hca Healthcare Inc
|
355.06 | 82.88B | 72.70B | 5.97B | 7.29B | 23.79 |
|
FMS
Fresenius Medical Care Ag Adr
|
25.80 | 15.35B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
160.89 | 14.50B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
109.96 | 10.91B | 5.51B | 494.70M | 386.40M | 4.84 |
|
DVA
Davita Inc
|
144.57 | 11.03B | 12.82B | 936.34M | 1.47B | 10.74 |
Universal Health Services Inc Stock (UHS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-02-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-06 | Fortgesetzt | BofA Securities | Neutral |
| 2024-10-16 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-07-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-07-26 | Hochstufung | Cantor Fitzgerald | Underweight → Neutral |
| 2024-06-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-20 | Hochstufung | UBS | Neutral → Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-11 | Hochstufung | Goldman | Sell → Buy |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-30 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-04-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Underweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Neutral |
| 2023-03-01 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-01-24 | Hochstufung | UBS | Sell → Neutral |
| 2023-01-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-16 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-03-29 | Eingeleitet | Wells Fargo | Underweight |
| 2022-02-28 | Herabstufung | Seaport Research Partners | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-24 | Eingeleitet | UBS | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-09-08 | Herabstufung | Goldman | Neutral → Sell |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Underweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-06-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-01-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-12-15 | Eingeleitet | Goldman | Neutral |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-06-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-23 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-26 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-18 | Herabstufung | Goldman | Buy → Neutral |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Outperform |
| 2018-01-03 | Eingeleitet | Goldman | Buy |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-10-11 | Eingeleitet | Stephens | Equal-Weight |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-27 | Hochstufung | Mizuho | Neutral → Buy |
Alle ansehen
Universal Health Services Inc Aktie (UHS) Neueste Nachrichten
UHS posts softer-than-expected volumes for second consecutive quarter - Healthcare Dive
Universal Health Services stock outlook improves as Cantor maintains neutral rating - Investing.com Canada
Universal Health Services, Inc. (NYSE:UHS) Q2 2025 Earnings Call Transcript - Insider Monkey
For-profit hospitals eye outpatient growth to blunt tax law cuts - Modern Healthcare
Universal Health Services Surges 5.08% as Trading Volume Spikes to $310M Ranking 375th on Earnings Beat and Strategic Reforms - AInvest
Universal Health Services Inc (UHS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance
Universal Health Services Inc (UHS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges - GuruFocus
Universal Health Services Reports Strong Q2 2025 Results - TipRanks
Universal Health Services Balances Growth and Challenges in Earnings Call - TipRanks
Universal Health Services could lose up to $400M in Medicaid supplemental payments in 2032 - Inquirer.com
Universal Health Services Inc. Cl B stock outperforms competitors on strong trading day - MarketWatch
Universal Health Services Q2 2025: Key Contradictions in Growth Expectations and Revenue Projections - AInvest
UHS CEO Marc Miller: OBBBA ‘Simply Can’t Be Left As Is’ - Behavioral Health Business
Behavioral Segment Concerns Overshadow Universal Health Q2 Earnings Beat - Benzinga
Universal Health Q2 Earnings Beat on Strong Acute Care Admissions - The Globe and Mail
Universal Health Q2 Earnings Jump 24% - The Motley Fool
Universal Health Services stock price target maintained at $226 by TD Cowen - Investing.com Canada
Earnings call transcript: Universal Health Services beats Q2 2025 EPS forecast - Investing.com
Universal Health Services beats quarterly profit estimates on higher medical care demand - Reuters
Universal Health Services stock maintains Buy rating at UBS on strong Q2 results - Investing.com Canada
Universal Health Services Inc (UHS) Q2 2025 Earnings: EPS of $5.43 Beats Estimates, Revenue Hits $4.284 Billion - GuruFocus
Universal Health Services, Inc. Announces Financial Results - TradingView
Universal Health 2025 Q2 Earnings Beats Expectations as Net Income Rises 23.2% - AInvest
Universal Health Services (UHS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
Universal Health Services: Q2 Earnings Snapshot - CTPost
Universal Health Services: Sustaining Outperformance in a Dynamic Healthcare Landscape - AInvest
Universal Health Services’s (NYSE:UHS) Q2 Sales Beat Estimates - Yahoo Finance
Universal Health Services (UHS) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Universal Health Realty Income Trust Reports Financial Results - TradingView
Universal Health Services beats Q2 expectations, raises full-year outlook - Investing.com Australia
Universal Health Services earnings beat by $0.42, revenue topped estimates - Investing.com Canada
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2025, AND INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST - Yahoo Finance
Universal Health Services (UHS) Earnings Report Expected Soon - GuruFocus
Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term - sharewise.com
Universal Health Services (UHS) Set to Release Q2 Earnings with Strong Track Record - GuruFocus
Universal Health Services Q2 2025 Earnings Preview: Revenue Expected to Rise 8.4% Y/Y - AInvest
Universal Health Services Set to Release Earnings Results Post-MarketNews and Statistics - IndexBox
Earnings To Watch: Universal Health Services (UHS) Reports Q2 Results Tomorrow - MSN
What makes Universal Health Services Inc. stock price move sharplyHigh Confidence Trade Setups - Metal.it
What institutions are buying Universal Health Services Inc. stock nowDynamic profit expansion - jammulinksnews.com
Universal Health Services Stock: Is UHS Outperforming the Healthcare Sector? - MSN
How UHS (UHS) Dividend Declaration Has Changed Its Investment Story - simplywall.st
(UHS) Investment Analysis and Advice - news.stocktradersdaily.com
Not Many Are Piling Into Universal Health Services, Inc. (NYSE:UHS) Just Yet - 富途牛牛
Universal Health to Report Q2 Earnings: What Do the Key Estimates Say? - MSN
Universal Health To Report Q2 Earnings: What Do The Key Estimates Say? - Barchart.com
Gear Up for Universal Health Services (UHS) Q2 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
Is Universal Health Services Inc. a good long term investmentHigh-octane financial growth - jammulinksnews.com
Universal Health Care | Pros, Cons, Debate, Arguments, Medicare, Medicaid, & Insurance - Britannica
Universal Health Services Inc. Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com
What analysts say about Universal Health Services Inc. stockUnprecedented growth rates - Autocar Professional
Finanzdaten der Universal Health Services Inc-Aktie (UHS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):